Exploration of Targets Potentially Linked to IL-17A Inhibitor Response in Psoriasis Using Machine Learning

The study reveals new insights into IL-17 inhibitors' mechanisms in psoriasis, suggesting that upregulation of CLCNKB and GFRA3, along with cytokine dysregulation (eg, IL-13, IL-10, IL-12, TGF-β, TNF-α), may underlie potential resistance and relapse in patients. This work demonstrates a novel approach to clinical outcome prediction with potential utility for specific clinical application, warranting further validation in clinical settings.